publication date: Jun. 29, 2018
Senate committee proposes $2 billion raise for NIH, signaling fourth good year in a row
By Jordan Williams and Matthew Bin Han Ong
When the Senate Committee on Appropriations marked up the fiscal 2019 spending bill, NIH came out ahead—$2 billion ahead.
Under the Senate bill, which was marked up June 28, NIH would receive $39.1 billion. If the bill is enacted, federally-funded biomedical research would get its fourth consecutive increase, and a substantial one at that.
Of the proposed $2 billion, $190 million in new money would trickle down to NCI.
The House version of the Labor-HHS spending bill, published June 14, proposes a $1.25 billion increase for NIH, bringing the total to $38.3 billion.
The president’s budget proposal initially sought to cut NIH budget by 27 percent, but after Congress raised the spending caps, the White House largely reversed the cut, adding back $9 billion, thereby bringing NIH funding back to the FY 2017 level (The Cancer Letter, Feb. 16).
Here is how the numbers line up for NCI:
In the Senate bill, NCI stands to receive $6.15 billion, with $400 million in Cancer Moonshot funds coming from the NIH Innovation Account. The bill also includes $30 million for NCI’s facility in Frederick.
In the House bill, NCI would receive $6.13 billion, also with the Moonshot included.
Under the White House proposal, NCI would get $5.626 billion. This number, too, includes the Moonshot.
“Congress is hard at work … Continue reading Senate committee proposes $2 billion raise for NIH, signaling fourth good year in a row
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.